L01XE Protein kinase inhibitors

RX_L01XE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L01XE

1538

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

1217

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

1217

diagram downward connector

Include endpoints None

1217

diagram downward connector
RX_L01XE

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 1174 607 567
Unadjusted prevalence (%) 0.38 0.35 0.42
Mean age at first event (years) 65.22 63.51 67.05

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_L01XE – L01XE Protein kinase inhibitors
GWS hits:

Survival analyses between endpoints

Plot

before L01XE Protein kinase inhibitors
after L01XE Protein kinase inhibitors

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L01XE Protein kinase inhibitors